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Methicillin-resistant Staphylococcus aureus is increasingly responsible for staphylococcal outbreaks in prison.
There is limited information on the source of the outbreak strains, risk factors for infection, and transmission
of these strains within a prison. We conducted a survey to determine the prevalence of nasal colonization
with S. aureus in 2 New York State prisons. S. aureus isolates from clinical cultures collected from all New
York State prisons during a 6-month period were compared with the colonizing strains. Analyses were con-
ducted to determine whether prison-level characteristics were associated with colonization or infection with
S. aureus. The colonization rate was 25.5% (124/487); 10.5% of the isolates were methicillin resistant, all were
staphylococcal chromosomal cassette (SCC)mec type IV, and 61.5% were Panton Valentine leukocidin (PVL)
positive. Surprisingly, 21.6% of the methicillin-susceptible isolates were also PVL positive. Of the clinical
isolates, 48.3% were methicillin resistant, with 93.1% of the latter being SCCmec type IV and 48.3% being
PVL positive. The predominant clone was USA 300. Prison-level risk factors for infection included the pro-
portion of inmates with drug offenses, the length of inmate stay, and the jail from which inmates originated.
This study suggests that both new and long-term inmates act as sources of S. aureus strains, with the more
virulent of the latter preferentially being selected as pathogens.
The epidemiology of Staphylococcus aureus infections
is evolving [1]. Traditionally associated with infections
in the health-care setting, antibiotic-resistant S. aureus
infections increasingly occur in the community [2, 3].
These community-based infections, especially those due
to methicillin-resistant S. aureus (MRSA), have oc-
curred in such diverse groups as children, Native Amer-
icans, members of athletic teams, military recruits, and
prison inmates [2–6]. Investigations of the circum-
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stances leading to these infections have primarily fo-
cused on outbreaks, and, as a result, there is limited
information on the prevalence of staphylococcal col-
onization and infection among high-risk groups in a
nonoutbreak setting. One such high-risk group is
prison inmates. Even though numerous staphylococcal
outbreaks have been identified in both jails and prisons
throughout the United States, there is a paucity of data
on the endemic prevalence and transmission dynamics
of CA-MRSA among incarcerated populations [7–9].
In particular, there are questions about whether S. au-
reus colonization serves as a prelude to infection, as it
does in the health-care setting. In the present study, we
collected colonization isolates from 2 prisons and com-
pared the molecular and epidemiological characteristics
with those of isolates associated with clinical infections
from all New York State (NYS) prisons.
METHODS
Collection of anterior nasal-swab cultures to detect
carriage of S. aureus. A surveillance study of S. aureus
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nasal carriage was conducted at 2 NYS maximum-security pris-
ons: Bedford Hills and Sing Sing. Bedford Hills houses 792
female prisoners, and Sing Sing houses up to 1741 male pris-
oners. During several prison visits between October 2005 and
April 2006, a convenience sample of nasal-swab cultures for
determination of S. aureus colonization was collected. Inmates
were provided with an informational handout describing the
study and were asked whether they were willing to participate.
Samples were collected anonymously in the cell blocks, at the
infirmary, and in interview rooms. The anterior nares of each
inmate were sampled with a cotton-tipped swab (Becton Dick-
inson Culturette Systems). The study was reviewed and ap-
proved by the Columbia University Institutional Review Board
and the NYS Department of Correctional Services.
Retrieval of clinical S. aureus isolates. Clinical cultures
from all NYS prisons were sent to a central commercial mi-
crobiology laboratory (Medilabs, Elmwood Park, NJ). Between
January and June of 2006, this laboratory sent to our laboratory
all cultures positive for S. aureus. Cultures were provided with-
out subject identifiers but with a specimen number, the body
site from which the culture had been collected (in most
instances), and the name of the prison. All duplicate samples
from the same inmate (information provided by Medilabs) and
all samples that failed to yield S. aureus when recultured in the
laboratory were eliminated, leaving 60 clinical samples for
analysis.
Microbiologic evaluation of the samples. After incubation
in Todd Hewitt broth for 3 h at 37C, an aliquot from the
broth containing bacteria from the nasal-swab cultures was
plated onto mannitol salt agar for 48 h at 37C; the nasal-swab
cultures were incubated in broth in order to enhance retrieval
of S. aureus. In addition, an aliquot of this sample, reflective
of the original swab culture, was frozen, at 80C, for future
use if necessary. Positive colonies identified on the mannitol
salt agar were then confirmed as S. aureus by use of Staphaurex
(Remel). All clinical and colonization cultures positive for S.
aureus were further characterized by staphylococcal chromo-
somal cassette (SCC)mec typing [10, 11] and antibiotic-sus-
ceptibility testing performed by the Kirby-Bauer method [12].
Screening for the presence of Panton Valentine leukocidin
(PVL) was performed as described elsewhere [13].
All S. aureus isolates were further characterized by pulsed-
field gel electrophoresis (PFGE) using SmaI digestion, as de-
scribed elsewhere [14]. PFGE profiles were entered into the
Bionumerics archival database (version 4; Applied Maths), and
the strains were then compared by use of a dendrogram. Closely
related strains were defined as showing dendrogram-based sim-
ilarity that was 70% [15].
Data analysis. Demographic data from the NYS Depart-
ment of Correctional Services were obtained for 26 NYS prisons
that provided clinical ( ) or surveillance isolates (n p 60 n p
). Results were presented separately for the clinical isolates487
and the surveillance isolates, because the latter were obtained
only at Bedford Hills and Sing Sing.
Prisons were categorized by security level (maximum or me-
dium). Demographic data for each prison were available at 12
different time points during 12 months that covered the period
in which the clinical or surveillance isolates were obtained (2005
calendar year). For each prison, information on inmates’ age,
race, and drug offenses; the proportion of inmates coming from
New York City (Kings, New York County [Manhattan], Queens,
Richmond, and Bronx) jails and from NYS jails; and length of
inmate stay was averaged over the 12-month period for each
prison and then was averaged across prisons, by security level
(medium or maximum), as described below.
To summarize the average demographic information across
prisons, several steps were taken to analyze the data. For each
prison, inmate age was available, in 12 categories ranging from
16 to 65 years. Inmates in the 165-years-old category were
excluded because there was no information on that age range.
Weighted median age was calculated at each time point by
weighting the median of each category by the number of in-
mates in the category, summing these values over all categories,
and then dividing by the total number of inmates in those
categories. Data on length of inmate stay also were available,
in 10 categories ranging from 0 to 172 months; a length of
stay 172 months was coded as 72 months. To determine the
proportion of inmates coming from NYC jails versus all other
NYS jails, the frequency of inmates from Kings, New York
County, Queens, Richmond, and Bronx counties were summed
and divided by the total number of inmates in the correspond-
ing prison. To provide the most representative demographic
characteristics of the inmates from whom we obtained isolates
during the study period, we took advantage of prison demo-
graphic data that were presented almost monthly (in some cases
bimonthly) during the 12-month period. The average demo-
graphic characteristics were calculated by averaging the pro-
portion of inmates with specific characteristics during each of
the available 12 time points during the 12-month period. Next,
the prison-level demographic averages were averaged over all
prisons, by security level (maximum or medium).
To assess potential demographic risk factors associated with
the isolation of MRSA in clinical cultures, the prison-level de-
mographic characteristics were collapsed over a 3-month period
before the S. aureus clinical isolates were obtained. These anal-
yses did not include surveillance isolates or clinical isolates from
either Bedford Hills or Sing Sing, because the variability in the
time frame during which surveillance was conducted was in-
sufficient to allow assessment of demographic predictors.
To compare the average demographic data for medium-se-
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Table 1. Average demographic characteristics of inmates in








Average length of inmate stay, months 24.5 14.5
Average weighted age of inmates,
median, yearsc 35.8 33.9
Average proportion of inmates, %




Other race/ethnicity 2.3 2.4
Average total of inmates, no. 1071 1205
a Except for age (see footnote c), the averages of the demographic char-
acteristics were calculated by averaging the proportion of inmates in each
prison who had each of the specific characteristics during each of the available
time points during the 12-month period. The prison-level demographic aver-
ages were then averaged over all prisons in each of the security-level cate-
gories (i.e., maximum and medium).
b Information on prison location was unavailable for 3 of the available
isolates.
c Average weighted median age was computed on the basis of categorical
data; the median of each of the age group was multiplied by the number of
inmates in that category, and the results was summed and divided by the
number of inmates in all age groups. These weighted medians were averaged
over 12 time points.
Table 2. Average demographic characteristics of inmates in




( )n p 236
Sing Sing
( )n p 251
Sex Female Male
Average length of inmate stay, months 36.5 25.7
Average weighted age of inmates,
median, yearsb 34.9 35.4
Average proportion of inmates, %
From New York City jails 47.7 72.1




Other race/ethnicity 2.1 2.4
Average total of inmates, no. 807.1 1737.1
a Except for age (see footnote b), the averages of the demographic char-
acteristics were calculated by averaging the proportion of inmates in each
prison who had each of the specific characteristics during each of the available
time points during the 12-month period. The prison-level demographic aver-
ages were then averaged over all prisons in each of the security-level cate-
gories (i.e., maximum and medium).
b Average weighted median age was computed on the basis of categorical
data; the median of each of the age group was multiplied by the number of
inmates in that category, and the results was summed and divided by the
number of inmates in all age groups. These weighted medians were averaged
over 12 time points.
curity versus those for maximum-security prisons, Student’s t
tests for differences in means were used to generate P values
for differences in average characteristics. To assess molecular
differences (i.e., MRSA, PVL, and clonal group [USA 300 vs.
other]) between clinical and colonization isolates, x2 or Fisher’s
exact test was used.
We conducted linear regression analyses by prison-security
level to assess whether prison-level characteristics were asso-
ciated with S. aureus outcomes among prisons (except Bedford
Hills and Sing Sing) providing clinical isolates. Two separate
outcomes were examined: (1) the proportion of SCCmec-pos-
itive isolates (total no. of SCCmec-positive isolates/total no. of
S. aureus clinical isolates) and (2) the proportion of PVL (no.
of PVL-positive isolates/total no. of S. aureus clinical isolates).
Predictor variables included average weighted median inmate
age, proportion of inmates in racial categories, average length
of inmate stay, proportion of inmates emanating from NYC
jails, and proportion of inmates with drug offenses. Results are
presented as linear regression slope estimates (b) and SE; sur-
veillance isolates from Bedford Hills and Sing Sing were not
analyzed by linear regression analyses, because there was very
little variability in the sampling period.
RESULTS
A total of 487 nasal swabs (236 from Bedford Hills and 251
from Sing Sing) were obtained for surveillance. During the same
period, 60 unique isolates of S. aureus from clinical cultures
from 26 NYS prisons were provided. The clinical isolates were
collected from the following sites: skin/soft tissue, 41; blood,
5; urine, 2; unknown, 12. Demographic characteristics of in-
mates in the maximum and medium-security NYS prisons who
provided clinical-infection isolates are shown in table 1. During
the 12-month period, the average proportion of inmates who
were from NYC jails was similar in the maximum- and me-
dium-security prisons (60.7% and 57.1%, respectively [P p
]). The average proportion of white versus black and His-.54
panic inmates in maximum-security prisons was lower than
that in medium-security prisons, but this difference was not
significant ( ). Demographic characteristics of the 2 pris-P p .24
ons (Bedford Hills and Sing Sing) over the time period when
samples were collected for surveillance cultures are shown in
table 2. The average proportion of inmates at Sing Sing who
were from NYC jails was higher than that at Bedford Hills
(72.2% and 47.7%, respectively [ ]). The proportionP ! .0001
of inmates who were drug offenders was higher at Bedford Hills
than at Sing Sing ( ).P ! .0001
The overall S. aureus nasal colonization rates for the 2 sur-
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Table 3. Characterization of Staphylococcus aureus nasal colonization and clinical isolates from inmates
in New York State prisons.
Categorya









S. aureus positive 27.5 (69/251) 23.3 (55/236) 25.5 (124/487) 100 (60)
MRSA positive/total S. aureus positive 2.9 (2/69) 20 (11/55) 10.5 (13/124) 48.3 (29/60)
SCCmec type IV/MRSA positive 100 (2/2) 100 (11/11) 100 (13/13) 93.1 (27/29)
PVL-positive MSSA/total MSSA 0 (0/67) 54.5 (24/44) 21.6 (24/111) 32.2 (10/31)
PVL-positive MRSA/total MRSA 0 (0/2) 72.7 (8/11) 61.5 (8/13) 48.3 (14/29)
a MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus; PVL, Panton Valentine leukocidin; SCC, staphy-
lococcal chromosomal cassette.
veillance site prisons were similar (Sing Sing, 27.5%; Bedford
Hills, 23.3%). The MRSA colonization rates at both facilities
were higher than those found in the general population [16,
17]. Interestingly, the rate in the women’s prison, Bedford Hills,
was ∼7 times that in the men’s prison, Sing Sing (20.0% [11/
55] and 2.9% [2/69] [ , by Fisher’s exact test]). AllP p .0026
of the MRSA colonization isolates from both prisons were
SCCmec type IV (table 3).
The percentage of MRSA among the isolates from clinical
cultures was higher than that among isolates from colonization
cultures (48.3% and 10.5%, respectively [ ]). Of theP ! .0001
MRSA isolates, 48.3% (14/29) were PVL positive. Surprisingly,
32.2% of the methicillin-susceptible S. aureus (MSSA) strains
were also PVL positive. PVL-positive MSSA and MRSA strains
were disproportionately represented among the clinical isolates:
overall, 25.8% (32/124) of the colonizing isolates were PVL
positive, whereas 40.0% (24/60) of the clinical isolates were
PVL positive ( ) (table 3). Among the clinical isolatesP p .0498
from all NYS prisons, there were 4 from Bedford Hills and 1
from Sing Sing; 4 of these 5 were MRSA.
When 70% similarity was used as the cutoff value, 13 clusters
of closely related strains were identified in the total sample
(both clinical and colonization isolates) (figure 1; data for col-
onization isolates are not shown). Isolates from both coloni-
zation and clinical cultures were represented in 12 of these 13
clones. All but 5 of the clinical isolates were also present among
the surveillance strains. The predominant clone identified in
the colonization isolates was USA 300, which was present in
20 of 124 isolates; 14 (70%) of these 20 USA 300 strains were
methicillin susceptible. Only 4 of the USA 300 strains were PVL
positive (data not shown). USA 300 accounted for 48.3% (29/
60) of the clinical isolates. The second largest group was USA
400, with 18 isolates (9 colonization and 9 clinical isolates). A
total of 15 of these isolates were methicillin susceptible, and 2
were PVL positive.
When the statistical associations between prison-level char-
acteristics (inmates’ average weighted median age, proportion
of inmates in race categories, average length of inmate stay,
proportion of inmates emanating from NYC jails, and pro-
portion of inmates with drug offenses) and the proportion of
PVL- and MRSA-positive isolates were examined in terms of
prison-security level, both a higher average age and a higher
proportion of inmates from NYC jails who were in medium-
security prisons were associated with lower levels of PVL pres-
ence among clinical S. aureus isolates (age slope, 0.025 [SE,
0.012] [ ]; NYC-jails slope, 0.806 [SE, 0.346] [P p .046 P p
]). In maximum-security prisons, a longer length of stay.027
was associated with an increased proportion of PVL presence
among S. aureus isolates from clinical infections (length-of-stay
slope, 0.011 [SE, 0.003] [ ]).P p .003
In medium-security prisons, older age and longer average
length of stay were significantly associated with a lower pro-
portion of MRSA infection (older-age slope, 0.037 [SE, 0.010
[ ]; length-of-stay slope, 0.010 [SE, 0.006] [P p .001 P !
]). In both maximum- and medium-security prisons, a.130
higher proportion of inmates with drug offenses was associated
with a significantly higher proportion of MRSA-positive clinical
isolates (maximum security–prison MRSA slope, 3.774 [SE,
0.908] [ ]; medium security–prison MRSA slope, 1.559P ! .001
[SE, 0.663] [ ]). Ethnicity was not a contributing factorP p .025
in either medium- or maximum-security prisons.
DISCUSSION
In the present study, we investigated S. aureus colonization and
clinical infection, during a defined time period, in NYS prisons.
Surveillance cultures were collected at 2 maximum-security
prisons, and culture data for the entire prison system were
collected during the same time period. There are a number of
interesting observations. The predominant strain, USA 300, was
identified in both the colonizing and infecting isolates. Inter-
estingly, these clones, whether methicillin susceptible or meth-
icillin resistant, were preferentially selected as pathogens, ac-
counting for a far higher proportion of the clinical infections
than did the other colonizing isolates. This result suggests that
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Figure 1. Clinical Staphylococcus aureus isolates collected from inmates in New York State prisons during a 6-month period (January–June 2006).
The dendrogram of pulsed-field gel electrophoresis (PFGE) profiles depicts the degree of relatedness of the strains. The first, second, and third columns
to the right of the gels indicate, respectively, the prison site where the isolate was collected, the staphylococcal chromosomal cassette (SCC)mec
type (when the strain is methicillin-resistant S. aureus positive), and the presence or absence of the Panton Valentine leukocidin (PVL) gene. Representative
PFGE profiles for USA 300 and USA 400 are included for comparison. MSSA, methicillin-susceptible S. aureus.
these strains are more effective as pathogens than are the other
colonizing strains.
PVL-positive strains accounted for a high proportion of the
clinical isolates. PVL has been identified as an epidemiologic
marker for, if not virulence determinant of, invasive strains of
CA-MRSA [18, 19]. Whether PVL is the virulence determinant
or a marker for other determinants remains uncertain; there
is relatively limited information on carriage versus infection
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with PVL-positive strains. The present study provides addi-
tional evidence of the ability of these unique CA-MRSA strains
to cause invasive disease.
The role that PVL-positive MSSA strains play as community
pathogens is also gaining increased attention. In their survey
of cutaneous infections treated in emergency departments
throughout the United States, Moran et al. [20] reported that
31% of MSSA isolates causing infections were USA 300 and
that 42% were PVL positive. MSSA PVL-positive isolates were
recently responsible for an outbreak of infections at a Rockland
County jail [21]. This outbreak is noteworthy because inmates
from this jail are transferred to NYS prisons; inmate transfers
may therefore be responsible for the introduction of these
strains into the prison system.
The vast majority of clinical infections were caused by the
same strains of S. aureus that were colonizing inmates in the
present study. Carriage of CA-MRSA has been implicated as a
risk factor in several of the diverse settings in which outbreaks
have occurred, including among military recruits, a group with
risks for infection that are similar to those for prison inmates
[5]; Ellis et al. [5] found that 38% of military recruits colonized
with CA-MRSA developed infections (all were PVL positive),
versus only 3% of those colonized with methicillin-susceptible
isolates. The role of antecedent nasal colonization as a prelude
to clinical infection is less clear in CA infections than in health
care–associated infections [4, 5, 22, 23]. This may be due in
part to the ability of these strains to colonize other unsampled
tissue sites (e.g., vagina, rectum, or skin) [24]; and such sites
may play a more important role in community-based infections
than in health care–associated infections.
Outbreaks of CA-MRSA infections in prisons have been in-
creasingly reported. Most notable among these have been the
large-scale outbreaks reported by Texas prisons, Los Angeles
county jails, a Mississippi prison, and the Georgia prison system
[6, 25, 26]. The risk factors identified in these outbreaks have
reflected the conditions found in other CA-MRSA–outbreak
settings and include close contact, compromised skin integrity,
and limited access to adequate hygiene.
MRSA-outbreak investigations and cross-sectional studies of
inmates in correctional facilities have identified some significant
demographic risk factors, including comorbidities, female sex
(for staphylococcal colonization), and longer incarceration. The
much higher MRSA colonization rates among the female in-
mates at Bedford Hills than among the male inmates at Sing
Sing may have to do with several factors: (1) the greater pro-
portion of women than men with drug-related offenses; (2)
differences in referral patterns from NYS jails; and (3) perhaps
differences in the nature of physical contact within the prisons.
Our earlier review of the literature regarding MRSA in prison
populations concluded that there is a need to identify risk
factors for MRSA in the prison setting and to better understand
the characteristics that influence acquisition and transmission
in this setting [27].
There are no studies of which we are aware that have iden-
tified a higher proportion of drug offenders as being a risk
factor for MRSA infection at the prison level. Data from the
US Department of Justice show that drug use is prevalent prior
to incarceration and is often concomitant with the timing of
the criminal offense: in 1997, 56.1% of men and 62.4% of
women reported drug use during the month prior to the of-
fense, and 32% of men and 40% of women reported drug use
at the time of the offense [28]; and, in 2001, a third of released
state-prison inmates had been convicted of a drug-related of-
fense [29]. Our finding of a much higher rate of colonization
among female inmates than among male inmates is consistent
with the results of previous surveys and warrants further eval-
uation. It is of interest that the women’s prison also had a
higher proportion of inmates with drug-related offenses, which
could explain some of the increased risk of colonization. For
the clinical isolates, a higher average proportion of inmates
with drug-use offenses in prison was strongly associated, in
both medium- and maximum-security prisons, with a higher
prevalence of clinical isolates that were MRSA positive. Taken
together, these findings suggest that drug use—or the behavioral
and/or epidemiological patterns associated with drug use—plays
an important role as a potential risk factor among inmates.
In maximum-security prisons, a longer length of inmate stay
was associated with an increased proportion of PVL-positive
isolates; in medium-security prisons, by contrast, length of in-
mate stay was negatively associated with MRSA infection. One
earlier study had identified longer length of inmate stay as a
risk factor for MRSA colonization during outbreaks [8]. It is
not clear why the present study found, in medium-security
prisons, a converse relationship between length of inmate stay
and MRSA infection. In medium-security prisons, younger age
was associated with an increase in PVL-positive isolates and in
MRSA clinical isolates. It is possible that younger inmates are
more susceptible, given that they are newer to the environment,
or that they may have more risk factors, such as recent drug
use; issues such as larger social networks or different forms of
interpersonal contact might also contribute to this finding.
The data of the present study would appear to support 2
hypotheses. The first hypothesis is that inmates enter prison
facilities with risk factors that increase the likelihood of colo-
nization and/or infection; antecedent drug use and the potential
risks of strain transmission [30], as well as incarceration in
particular NYS jails, may contribute to this hypothesis. The
second hypothesis is that prolonged incarceration in maxi-
mum-security prisons also increases inmates’ risk of infection,
perhaps because of increased likelihood of close contact with
inmates with S. aureus infection, especially in light of the prev-
alence of selected strains in the prison system.
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The present study had a number of limitations. The com-
parison between colonizing isolates and isolates associated with
clinical infection was limited because only 2 prisons were in-
cluded in the study of colonization whereas the clinical isolates
were obtained from all NYS prisons. It is of interest, though,
that the majority of clinical isolates were represented among
the colonization strains. From these data, it is difficult to draw
any conclusions regarding the likelihood or risk of clinical in-
fection. The proportion of MRSA among clinical isolates may
have been associated with interprison differences in the practice
of obtaining clinical cultures, which would clearly affect the
relative numbers of isolates obtained from the different prisons.
Nevertheless, the clinical isolates provided some insight into
the nature of the S. aureus isolates associated with clinical in-
fections in the NYS prison system.
Our coding of drug offenses may not have been mutually
exclusive, because inmates may have had more than 1 drug
offense listed; however, multiple offense classifications would
most likely lead to an underestimation of the effects that drug
offense has on infection levels. Our data were analyzed at the
prison level, and, therefore, it is not possible to infer that
prison-level risk factors identified in the present study are also
significant risk factors at the individual-inmate level. Last, only
approximately half of the inmates approached were willing to
volunteer to provide a nasal-swab specimen.
In summary, the present study illustrates both the value of
surveillance cultures in determining the prevalence of poten-
tially invasive strains of CA-MRSA in high-risk settings and the
ability of these strains to predominate as pathogens. It also
demonstrates the potential contribution that antecedent risk
factors and incarceration make to the likelihood of infection.
Further research is necessary to identify both individual and
contextual risk factors for S. aureus infection among prison
populations.
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